Your browser doesn't support javascript.
Middle East respiratory syndrome.
Memish, Ziad A; Perlman, Stanley; Van Kerkhove, Maria D; Zumla, Alimuddin.
  • Memish ZA; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Research Center, King Saud Medical City Ministry of Health, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Perlman S; Department of Microbiology and Immunology, and Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
  • Van Kerkhove MD; Infectious Hazards Management, Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
  • Zumla A; Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK; National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, UK. Electronic address: a.zumla@ucl.ac.uk.
Lancet ; 395(10229): 1063-1077, 2020 03 28.
Article in English | MEDLINE | ID: covidwho-3836
ABSTRACT
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34·3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / Coronavirus Infections / Epidemics / Middle East Respiratory Syndrome Coronavirus Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Animals / Child / Female / Humans / Pregnancy Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(19)33221-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / Coronavirus Infections / Epidemics / Middle East Respiratory Syndrome Coronavirus Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Animals / Child / Female / Humans / Pregnancy Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(19)33221-0